Carisma Therapeutics Inc. Stockholders' Equity Attributable to Noncontrolling Interest
Carisma Therapeutics Inc. had Stockholders' Equity Attributable to Noncontrolling Interest of $0 as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2024-04-01
- 2023-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $0.00.
- 2023-09-30: Stockholders' Equity Attributable to Noncontrolling Interest $0.00.
- 2023-06-30: Stockholders' Equity Attributable to Noncontrolling Interest $0.00.
- 2022-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $14.39M.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-04-01 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 |
| 2022-12-31 | $14.39M 10-K · filed 2024-04-01 |